Decheng Capital China Life Sciences USD Fund III, L.P.
CIK 1736814 · last filed 2025-09-11
Decheng Capital China Life Sciences USD Fund III, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2024. The most recent filing shows the insider sold $245.2K of BYSI on Sep 11, 2025. Across all open-market trades the lifetime net is −$245.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.94M
2
2
-$245.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BYSI | 10%+ Owner | 1,874,710 | $1.57 | $2.94M | -$245.2K | 1 | 2025-09-11 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | 10%+ Owner | 6,582,380 | $64.97 | $427.66M | $0 | 1 | 2024-01-22 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-11 | BYSI | Sell (S) | −126,276 | -$245.2K | EDGAR |
| 2024-01-22 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Exer (X) | +2,469,272 | $31.46M | EDGAR |